Home
Live Updates
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement : comparemela.com
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
NEW YORK, June 28, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) (
Related Keywords
,
Nasdaq Stock Market ,
Veris Health Inc ,
Veris Health ,
Lucid Diagnostics Inc ,
Nasdaq ,
Exchange Commission ,
Pavmed Inc ,
Nasdaq Listing Rule ,
Extension Notice ,
Veris Cancer Care ,
Lucid Diagnostics ,
Esophageal Cell Collection Device ,
Annual Report ,
Quarterly Report ,
Markets ,
comparemela.com © 2020. All Rights Reserved.